Michael Faia is the Head of R&D Portfolio Management at Harmony Biosciences. In this role, he provides strategic leadership across their preclinical and clinical portfolio, integrating drug development across all functions and translating strategy into execution to deliver medicines to patients. Prior to Harmony, Michael served as a project management leader with roles of progressive responsibility at Johnson & Johnson, MedImmune/AstraZeneca, and Jazz Pharmaceuticals.
Michael is a strategic thinker and proven high performer with nearly 25 years of global experience in product and program management, new product commercialization, and drug development in the pharma-biotech industry. He is an accomplished line and matrix team leader with experience building and developing project management organizations and project teams, managing multi-cultural change programs, establishing strategic direction, executing operational plans, and developing partnerships.
Michael earned BS and MS degrees in Chemical Engineering from Drexel University, an MS in Quality from Temple University, and an MBA from Pennsylvania State University. Michael holds multiple certifications from the Project Management Institute (PMI), is a Pennsylvania licensed Professional Engineer (PE), and Lean Six Sigma Black Belt (LSS BB).
More Info